Agnieszka Kuś - Search Results

Year	Number of Results
2005	1
2009	1
2010	2
2011	2
2012	2
2013	1
2017	1
2022	1
2023	1
2024	0

1

Potential of high-titre IgA convalescent plasma to improve survival and symptoms in COVID-19 patients.

Kuś A, Wieczorek S, Dybko J, Szymczyk-Nużka M, Butrym A, Makuch S, Mazur G, Agrawal S. Kuś A, et al. Eur J Clin Invest. 2023 Feb;53(2):e13928. doi: 10.1111/eci.13928. Epub 2022 Dec 10. Eur J Clin Invest. 2023. PMID: 36453977 Free PMC article.

2

Design and synthesis of CK2 inhibitors.

Makowska M, Łukowska-Chojnacka E, Wińska P, Kuś A, Bilińska-Chomik A, Bretner M. Makowska M, et al. Among authors: kus a. Mol Cell Biochem. 2011 Oct;356(1-2):91-6. doi: 10.1007/s11010-011-0953-8. Epub 2011 Jul 13. Mol Cell Biochem. 2011. PMID: 21750983

3

Frequency of infection with Helicobacter pylori isolates of different antimicrobial profiles in children and adolescents: A preliminary study.

Gościniak G, Biernat MM, Bińkowska A, Kus A, Iwańczak B. Gościniak G, et al. Among authors: kus a. Adv Clin Exp Med. 2017 Mar-Apr;26(2):263-268. doi: 10.17219/acem/67716. Adv Clin Exp Med. 2017. PMID: 28791844 Free article.

4

Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.

Lemay CG, Rintoul JL, Kus A, Paterson JM, Garcia V, Falls TJ, Ferreira L, Bridle BW, Conrad DP, Tang VA, Diallo JS, Arulanandam R, Le Boeuf F, Garson K, Vanderhyden BC, Stojdl DF, Lichty BD, Atkins HL, Parato KA, Bell JC, Auer RC. Lemay CG, et al. Among authors: kus a. Mol Ther. 2012 Sep;20(9):1791-9. doi: 10.1038/mt.2012.128. Epub 2012 Jul 3. Mol Ther. 2012. PMID: 22760544 Free PMC article.

5

TLR engagement prior to virus infection influences MHC-I antigen presentation in an epitope-dependent manner as a result of nitric oxide release.

Siddiqui S, Alatery A, Kus A, Basta S. Siddiqui S, et al. Among authors: kus a. J Leukoc Biol. 2011 Mar;89(3):457-68. doi: 10.1189/jlb.0610357. Epub 2010 Dec 22. J Leukoc Biol. 2011. PMID: 21178114

6

Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure.

Jankowska EA, von Haehling S, Czarny A, Zaczynska E, Kus A, Anker SD, Banasiak W, Ponikowski P. Jankowska EA, et al. Among authors: kus a. Eur J Heart Fail. 2005 Oct;7(6):984-90. doi: 10.1016/j.ejheart.2005.05.013. Epub 2005 Aug 19. Eur J Heart Fail. 2005. PMID: 16112903 Free article.

7

Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.

Gyenis L, Kuś A, Bretner M, Litchfield DW. Gyenis L, et al. Among authors: kus a. J Proteomics. 2013 Apr 9;81:70-9. doi: 10.1016/j.jprot.2012.09.017. Epub 2012 Sep 25. J Proteomics. 2013. PMID: 23017496

8

Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state.

Alatery A, Siddiqui S, Chan M, Kus A, Petrof EO, Basta S. Alatery A, et al. Among authors: kus a. Immunol Cell Biol. 2010 Jan;88(1):3-12. doi: 10.1038/icb.2009.90. Epub 2009 Nov 24. Immunol Cell Biol. 2010. PMID: 19935765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year